NOV 12, 2015 7:30 AM PST

Keynote: Reconceptualizing Genital Herpes Diagnosis and Management

Speaker
  • Professor of Medicine/Epidemiology/Microbiology, Director, Division of Infectious Diseases, The University of Alabama at Birmingham, Department of Medicine, Division of Infectious Diseases
    Biography
      Dr. Hook is a Professor of Medicine and Epidemiology at the University of Alabama, Birmingham, and Director of the STD Control Program for the Jefferson County (Alabama) Department of Health. Dr. Hook's laboratory has emphasized diagnostic testing for Neisseria gonorrhoeae, Chlamydia trachomatis and syphilis, providing a platform for a wide variety of studies. His laboratory is one of 5 CDC-funded reference laboratories for the Gonococcal Isolate Surveillance Project which has monitored trends in gonococcal epidemiology and antimicrobial resistance in the U.S. since 1988. In addition, data generated by his laboratories have reflected collaboration with other faculty of the Infectious Diseases Division and other Departments within the School of Medicine (Obstetrics and Gynecology, Pediatrics and Microbiology) and other UAB Schools (Public Health, Social and Behavioral Sciences).

      Dr. Hook's recent work has included: studies of health behavior and behavioral interventions for STD/HIV risk reduction; assessment of STD epidemiology; clinical trials of new therapeutic agents; and clinical evaluation of new diagnostic tests for diagnosis of gonorrhea, chlamydial infection and syphilis. Major ongoing research efforts include his role as PI on a randomized trial evaluation of non-invasive screening for gonococcal and chlamydial infections in adolescents seeking care at hospital emergency rooms and as Protocol Chair for a randomized trial evaluation of azithromycin for treatment of syphilis.

    Abstract

    As one of the nation's most prevalent sexually transmitted infections, genital herpes represents a diagnostic and therapeutic challenge to clinicians, laboratorians and the patients they serve.  Over the past 25 years there has been increasing appreciation that the infection is widespread, impacting over 45 million Americans, and is misunderstood in terms of how the infection is transmitted from person to person, in terms of optimal diagnostic strategies, and in terms of the goals of management for infected persons.  Nucleic acid amplification tests now offer more sensitive methods for virologic testing for the virus and proper use of type-specific serological tests can be helpful in detecting infection an guiding therapeutic decision making.  This presentation will provide an overview of current genital herpes management, emphasizing the role of laboratory testing to improve diagnosis and guide therapy to control clinical manifestations of infection and reduce risk for transmission to others.


    Show Resources
    You May Also Like
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    JUN 09, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    DEC 05, 2019 5:00 AM PST
    C.E. CREDITS
    DEC 05, 2019 5:00 AM PST
    DATE: December 5, 2019TIME: 5:00am PST, 8:00am EST The diagnosis of an active infection by the hepatitis B virus (HBV) relies on testing for the HBV surface antigen (HBsAg). Ov...
    FEB 19, 2020 11:00 AM PST
    C.E. CREDITS
    FEB 19, 2020 11:00 AM PST
    DATE: February 19, 2020TIME: 11:00am PST, 2:00pm EST...
    Loading Comments...
    Show Resources